Rosalab SRL
Rosalab reported total assets of 281,749 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026).
The score of Rosalab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -20 % Total assets +64 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rosalab's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 181,427 € | ||||
| Equity | 74,820 € | ||||
| Cash | 27,326 € | ||||
| EBITDA | 263,166 € | ||||
| Total assets | 281,749 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Rosalab's financial analysis
- Solvency26.6%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rosalab
Rosalab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0682.447.161
- VAT number
- BE0682447161
- Peppol
- Registered · 0208:0682447161 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Oct 2017
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Rosalab (SRL) has been based in Wavre since 2017, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 181,427 € and equity of 74,820 €; its revenue is not published. Its solvency stands at 26.6%, below the median of its sector (66.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Rosalab
Companies in the same business, of comparable size and area, outside its group.
- Oncogeb Uccle · balance sheet 390,573 €
- Röntgenium Diagnostic imaging services and medical laboratory activities Roeselare · balance sheet 323,198 €
- Coronis Other human health activities n.e.c. Duffel · balance sheet 302,255 €
- SPOTWATCH Antwerpen Photographic activities Aalter · balance sheet 572,244 €
- Laffut Wim Diagnostic imaging services and medical laboratory activities Lier · balance sheet €1.01m
- Dr. Els Van Essche, Reumatologie Other human health activities n.e.c. Herent · balance sheet 670,507 €
- Dr. Van Nuffel Jan Diagnostic imaging services and medical laboratory activities Lubbeek · balance sheet €1.17m
- Laser Refractie Centrum Diagnostic imaging services and medical laboratory activities Sint-Martens-Latem · balance sheet 498,382 €
Frequently asked questions about Rosalab
What is the revenue of Rosalab?
Rosalab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rosalab?
In Belgium, the VAT number is the company number prefixed with BE: BE0682447161 for Rosalab, if the company is VAT-registered. Its company number (CBE) is 0682.447.161.
Where is the registered office of Rosalab?
According to the CBE register, the registered office of Rosalab is in 1300 Wavre.
What is the equity of Rosalab?
At the close of the 2025 financial year, the equity of Rosalab amounts to 74,820 €, a solvency of 26.6% of total assets.
Who manages Rosalab?
The register lists 2 active mandates at Rosalab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rosalab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →